The active substance in Replagal is agalsidase alfa (1mg/ml). Agalsidase alfa is a form of the human enzyme ?-galactosidase. It is produced by switching on the gene for ?-galactosidase A in cells. The enzyme is then removed from the cells and made into a sterile concentrate for solution for...
Producer: Shire Human Genetic Therapies AB
Therapeutic group: Other alimentary tract and metabolism products